Bartosz Sikora
Overview
Explore the profile of Bartosz Sikora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skubis-Sikora A, Hudecki A, Sikora B, Wieczorek P, Hermyt M, Hreczka M, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335462
Polycaprolactone (PCL) is a biodegradable polyester that might be used in tissue engineering to obtain scaffolds for bone reconstruction using 3D-printing technologies. New material compositions based on PCL, with improved...
2.
Wystrychowski G, Simka-Lampa K, Witkowska A, Sobecko E, Skubis-Sikora A, Sikora B, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928349
The role of adipose mesenchymal stem cells (Ad-MSCs) in metabolic syndrome remains unclear. We aimed to assess the expression of selected microRNAs in Ad-MSCs of non-diabetic adults in relation to...
3.
Skubis-Sikora A, Sikora B, Malysiak W, Wieczorek P, Czekaj P
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765045
Melatonin is a hormone secreted mainly by the pineal gland and acts through the Mel1A and Mel1B receptors. Among other actions, melatonin significantly increases osteogenesis during bone regeneration. Human adipose-derived...
4.
Czekaj P, Krol M, Kolanko E, Limanowka L, Prusek A, Skubis-Sikora A, et al.
Front Biosci (Landmark Ed)
. 2023 May;
28(5):87.
PMID: 37258482
Background: In humans, chronic liver disease (CLD) is a serious clinical condition with many life-threatening complications. Currently, there is no therapy to stop or slow down the progression of liver...
5.
Czekaj P, Krol M, Limanowka L, Skubis-Sikora A, Kolanko E, Bogunia E, et al.
Front Biosci (Landmark Ed)
. 2022 Aug;
27(8):237.
PMID: 36042178
Background And Aims: Experimental models using carbon tetrachloride (CCl4) and D-galactosamine (D-GalN) can be used in preclinical assessment of acute liver failure (ALF) therapies. Unfortunately, these models are characterized by...
6.
Sikora B, Skubis-Sikora A, Prusek A, Gola J
Sci Rep
. 2021 Oct;
11(1):19956.
PMID: 34620960
Limbal stem cells deficiency (LSCD) is an eye disease caused by the loss of stem cells in the corneal limbus as a succession of an injury due physical, biological, or...
7.
Skubis-Sikora A, Sikora B, Witkowska A, Mazurek U, Gola J
Mol Med
. 2020 Jul;
26(1):67.
PMID: 32615920
Background: Adipose derived stem cells (ADSCs) are clinically widely used somatic stem cells obtained from white adipose tissue. They are characterized by ability to differentiate e.g. into osteoblasts and might...
8.
Sikora B, Skubis-Sikora A, Kimsa-Furdzik M, Ciszek W, Kostrzewski M, Stojko J, et al.
Stem Cell Res
. 2019 Nov;
41:101609.
PMID: 31706096
Mesenchymal stem cells (MSCs) are objects of interest in regenerative medicine. They are used for various therapies such as for the regeneration of bone, chondrocytes and other tissues. Adipose derived...
9.
Wcislo-Dziadecka D, Grabarek B, Zmarzly N, Skubis A, Sikora B, Kruszniewska-Rajs C, et al.
Biomed Res Int
. 2018 Mar;
2018:1582173.
PMID: 29487864
Objective: The aim of this study was to evaluate the influence of adalimumab on expression profile of genes associated with the histaminergic system in Normal Human Dermal Fibroblast (NHDF) cells...
10.
Skubis A, Gola J, Sikora B, Hybiak J, Paul-Samojedny M, Mazurek U, et al.
Int J Mol Sci
. 2017 Dec;
18(12).
PMID: 29186789
Adipose tissue is a promising source of mesenchymal stem cells. Their potential to differentiate and regenerate other types of tissues may be affected by several factors. This may be due...